"Karcinom pankreatu. Chirurgick\u00E1 strategie l\u00E9\u010Dby"@cs . . "5"^^ . "Radical resection is only method of treatment giving the chance for long-term survival in the patients with pancreatic cancer with 5-year survival 11\u201328 %. Czech Republic is in the incidence of pancreatic cancer in the 6.place in Europe. 70\u201380 % patients are irresectable in the moment of diagnosis. Patients with staging of T1-3, N0-1, M0 are indicated for radical resection with standard lymphadenectomy, resection of portomesenteric segment is indicated as a part of R0 resection. In the case of advanced carcinoma over that staging in patients in good condition palliative resection or biliodigestive anastomosis is indicated, in other cases endoscopic stenting. Extended resections did not prove the benefit for patients"@en . "4" . "pancreatic cancer; surgical therapy; results"@en . . "Radik\u00E1ln\u00ED resekce je jedinou metodou l\u00E9\u010Dby, kter\u00E1 u nemocn\u00FDch s karcinomem pankreatu d\u00E1v\u00E1 re\u00E1lnou \u0161anci na dlouhodob\u00E9 p\u0159e\u017Eit\u00ED a je potencion\u00E1ln\u011B kurabiln\u00ED. P\u011Btilet\u00E9 p\u0159e\u017Eit\u00ED po R0 resekci s adjuvantn\u00ED chemoterapi\u00ED je uv\u00E1d\u011Bno v rozmez\u00ED 11\u201328 %. \u010Cesk\u00E1 Republika se ve v\u00FDskytu karcinomu pankreatu nach\u00E1z\u00ED na 6. m\u00EDst\u011B v Evrop\u011B. 70\u201380 % nemocn\u00FDch je v dob\u011B stanoven\u00ED diagn\u00F3zy neresekabiln\u00EDch. K radik\u00E1ln\u00ED resekci indikujeme nemocn\u00E9 se stagingem T1-3, N0-1, M0. Radik\u00E1ln\u00ED resekce je dopln\u011Bna standardn\u00ED lymfadenektomi\u00ED, resekce portomezenterick\u00E9ho \u017Eiln\u00EDho segmentu je indikov\u00E1na v r\u00E1mci R0 resekce. P\u0159i n\u00E1lezu p\u0159esahuj\u00EDc\u00EDm tento staging je indikov\u00E1na u nemocn\u00FDch v celkov\u011B dobr\u00E9m stavu paliativn\u00ED resekce \u010Di v p\u0159\u00EDpad\u011B ikteru biliodigestivn\u00ED anastom\u00F3za, v ostatn\u00EDch p\u0159\u00EDpadech endoskopick\u00E9 zaveden\u00ED stentu. Roz\u0161\u00ED\u0159en\u00E9 resekce neprok\u00E1zaly signifikantn\u00ED benefit pro pacienta." . . "Pancreatic cancer \u2013 surgical treatment strategy"@en . "Karcinom pankreatu. Chirurgick\u00E1 strategie l\u00E9\u010Dby" . . "CZ - \u010Cesk\u00E1 republika" . . "RIV/61383082:_____/10:1600!RIV11-MO0-61383082" . . . "Karcinom pankreatu. Chirurgick\u00E1 strategie l\u00E9\u010Dby"@cs . "Onkologie" . . "Ryska, Miroslav" . "Pancreatic cancer \u2013 surgical treatment strategy"@en . . "1802-4475" . "[A6CE4629351C]" . "Radik\u00E1ln\u00ED resekce je jedinou metodou l\u00E9\u010Dby, kter\u00E1 u nemocn\u00FDch s karcinomem pankreatu d\u00E1v\u00E1 re\u00E1lnou \u0161anci na dlouhodob\u00E9 p\u0159e\u017Eit\u00ED a je potencion\u00E1ln\u011B kurabiln\u00ED. P\u011Btilet\u00E9 p\u0159e\u017Eit\u00ED po R0 resekci s adjuvantn\u00ED chemoterapi\u00ED je uv\u00E1d\u011Bno v rozmez\u00ED 11\u201328 %. \u010Cesk\u00E1 Republika se ve v\u00FDskytu karcinomu pankreatu nach\u00E1z\u00ED na 6. m\u00EDst\u011B v Evrop\u011B. 70\u201380 % nemocn\u00FDch je v dob\u011B stanoven\u00ED diagn\u00F3zy neresekabiln\u00EDch. K radik\u00E1ln\u00ED resekci indikujeme nemocn\u00E9 se stagingem T1-3, N0-1, M0. Radik\u00E1ln\u00ED resekce je dopln\u011Bna standardn\u00ED lymfadenektomi\u00ED, resekce portomezenterick\u00E9ho \u017Eiln\u00EDho segmentu je indikov\u00E1na v r\u00E1mci R0 resekce. P\u0159i n\u00E1lezu p\u0159esahuj\u00EDc\u00EDm tento staging je indikov\u00E1na u nemocn\u00FDch v celkov\u011B dobr\u00E9m stavu paliativn\u00ED resekce \u010Di v p\u0159\u00EDpad\u011B ikteru biliodigestivn\u00ED anastom\u00F3za, v ostatn\u00EDch p\u0159\u00EDpadech endoskopick\u00E9 zaveden\u00ED stentu. Roz\u0161\u00ED\u0159en\u00E9 resekce neprok\u00E1zaly signifikantn\u00ED benefit pro pacienta."@cs . "1"^^ . "6" . . "Karcinom pankreatu. Chirurgick\u00E1 strategie l\u00E9\u010Dby" . . . "RIV/61383082:_____/10:1600" . . "1"^^ . "266100" . . "P(NS9994), V" . . .